Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Redwood City, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Jasper Therapeutics, Inc. has filed 469 SEC EDGAR filings since 13 Sep 2019

SEC filing history

Showing 276-300 of 469 matching filings.

Per page
25
Current page
12
UPLOAD

UPLOAD filing

Filing date
13 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-260306

POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1

Filing date
07 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-267777

REGISTRATION STATEMENT

Filing date
07 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-260306

PROSPECTUS SUPPLEMENT

Filing date
12 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39138

QUARTERLY REPORT

Filing date
12 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
12 Aug 2022
Reporting date
12 Aug 2022
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
11 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91228

SC 13D/A

Filing date
11 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Jun 2022
Reporting date
24 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
27 Jun 2022
Reporting date
23 Jun 2022
Next action
Verify source filing
424B3 File 333-260306

PROSPECTUS SUPPLEMENT NO. 1

Filing date
12 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39138

QUARTERLY REPORT

Filing date
12 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
12 May 2022
Reporting date
12 May 2022
Next action
Verify source filing
DEFA14A File 001-39138

DEFINITIVE ADDITIONAL MATERIALS

Filing date
29 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39138

DEFINITIVE PROXY STATEMENT

Filing date
29 Apr 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91228

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
28 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
27 Apr 2022
Reporting date
27 Apr 2022
Next action
Verify source filing
4

4 filing

Filing date
08 Apr 2022
Reporting date
07 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-260306

PROSPECTUS

Filing date
01 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-260306

EFFECT filing

Filing date
29 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-260306

POST EFFECTIVE REGISTRATION STATEMENT

Filing date
24 Mar 2022
Reporting date
Not listed
Next action
Verify source filing
4

4 filing

Filing date
23 Mar 2022
Reporting date
21 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Mar 2022
Reporting date
21 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Mar 2022
Reporting date
21 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Mar 2022
Reporting date
21 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .